Higher genetically determined serine protease 27 (PRSS27) was associated with higher SBP, higher DBP and higher PP, while higher genetically determined levels of Neurocan (NCAN) were associated with lower risk of T2D (OR = 0.76) and 0.07-SD lower SBP. The gene discussed is NCAN; the disease is type 2 diabetes mellitus.